Corticosteroid-responsive aseptic meningitis during regorafenib treatment

Neurooncol Pract. 2019 Dec;6(6):508-509. doi: 10.1093/nop/npz030. Epub 2019 Jul 18.

Irina Gepfner-Tuma^{1

2}, Sophie Hirsch¹, Jens Schittenhelm^{2

3}, Theophilos Tzaridis⁴, Ulf Ziemann^{1

2}, Marcos Tatagiba^{1

2}, Ulrich Herrlinger⁵, Ghazaleh Tabatabai^{1

2

6}

¹ Interdisciplinary Division of Neuro-Oncology, Departments of Neurology and Neurosurgery, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Germany.
² Center for CNS Tumors, Comprehensive Cancer Center Tübingen, Stuttgart; Eberhard Karls University Tübingen, Germany.
³ Department of Neuropathology, University Hospital of Tübingen, Eberhard Karls University of Tübingen, Germany.
⁴ Division of Clinical Neuro-Oncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn.
⁵ Division of Neuro-Oncology, Department of Neurology and Center of Integrated Oncology, University Hospital Bonn, Bonn, Germany.
⁶ German Consortium for Translational Oncology (DKTK), DKFZ partner site Tübingen.

No abstract available